Source link : https://newshealth.biz/health-news/meta-analysis-compares-hidradenitis-suppurativa-treatments/

TOPLINE: In a network meta-analysis of 25 randomized trials, sonelokimab was ranked highest for treating patients with moderate-to-severe hidradenitis suppurativa (HS). Adalimumab, lutikizumab, and bimekizumab were also ranked high. METHODOLOGY: Researchers conducted a systematic review and network meta-analysis of 25 phase 2 and 3 randomized clinical trials of medical treatments for adults with moderate-to-severe HS […]

The post Meta-Analysis Compares Hidradenitis Suppurativa Treatments first appeared on News Health.

—-

Author : News Health

Publish date : 2025-07-03 03:05:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678